Taconic Capital Advisors’s Tevogen Bio Holdings TVGN Stock Holding History

Taconic Capital Advisors’s Portfolio TVGN Stock Details TVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-20,036	Closed	-$10.3M	–	321
2022 Q4	$10.3M	Hold	20,036	–	–	0.29%	60
2022 Q3	$10.2M	Hold	20,036	–	–	0.25%	72
2022 Q2	$10M	Hold	20,036	–	–	0.26%	72
2022 Q1	$10M	Buy	+20,036	New	+$9.96M	0.27%	57

Other funds holding TVGN

CCP

Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return

FCM

FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Taconic Capital Advisors's TVGN Position: Q1 2023 in Review

Taconic Capital Advisors sold out of Tevogen Bio Holdings (TVGN) in Q1 2023, closing a stake of 20,036 shares — an estimated $10.3M sold.

Taconic Capital Advisors first reported a position in TVGN in Q1 2022 and held it in 4 quarters. The position peaked at $10.3M in Q4 2022. 4 funds tracked by Wall St. Rank hold TVGN as of Q1 2023.

Taconic Capital Advisors reported no remaining Tevogen Bio Holdings position as of Q1 2023 after selling out during the quarter.
Taconic Capital Advisors sold 20,036 Tevogen Bio Holdings shares in Q1 2023, an estimated $10.3M.
Taconic Capital Advisors first reported a position in Tevogen Bio Holdings in Q1 2022 and held it in 4 quarters.
Taconic Capital Advisors's Tevogen Bio Holdings position peaked at $10.3M in Q4 2022.
4 funds tracked by Wall St. Rank held Tevogen Bio Holdings as of Q1 2023.

Based on Taconic Capital Advisors's 13F filing for Q1 2023, filed 15 May 2023.